Clinical trial shows improved rare blood cancer treatment
A new drug called momelotinib reduces the need for blood transfusions in anemic patients suffering from myelofibrosis.
The post Clinical trial shows improved rare blood cancer treatment appeared first on Advanced Science News.
Published at Thu, 23 Jun 2022 07:11:40 +0000